Recent News for MGNX - MacroGenics, Inc.

Date Title
May 29 MacroGenics (MGNX) Presents At ASCO 2020 - Slideshow
May 29 Here's Why MacroGenics Is Tumbling 17.3% Today
May 29 The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
May 28 FDA nixes Ad Com review for MacroGenics' margetuximab
May 28 MacroGenics Provides Update on FDA Review of Margetuximab for HER2-Positive Metastatic Breast Cancer
May 27 MacroGenics Announces Registration Study of Flotetuzumab in Patients with Refractory Acute Myeloid Leukemia
May 21 MacroGenics to Host Conference Call and Webcast to Review Preliminary Clinical Results for MGD013 and MGC018 to be Presented at ASCO
May 18 What You Need To Know About The MacroGenics, Inc. (NASDAQ:MGNX) Analyst Downgrade Today
May 16 MacroGenics Reports Data, And Other News: The Good, Bad And Ugly Of Biopharma
May 14 5 ASCO Abstracts Moving Biopharma Stocks
May 14 MacroGenics under pressure on early-stage data on cancer candidates
May 14 32 Stocks Moving in Thursday's Pre-Market Session
May 13 MacroGenics announces interim clinical results from MGD013 and MGC018; shares down ~20%
May 13 MacroGenics Announces Preliminary Clinical Results from MGD013 and MGC018 to be Presented at the ASCO Annual Meeting
May 13 The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
May 12 MacroGenics up 7% on bullish call at Credit Suisse ahead of ASCO data
May 12 Are Options Traders Betting on a Big Move in MacroGenics (MGNX) Stock?
May 12 The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings
May 11 Why MacroGenics Stock Jumped 29% Today
May 11 Optimism Runs High for MacroGenics
May 11 3 Small-Cap Biotech Stocks That Surged Last Week
May 9 Spotlight On Tech Momo, Bitcoin Halving And 13Fs
May 8 Why MacroGenics, Inc.'s (NASDAQ:MGNX) CEO Pay Matters To You
May 8 MacroGenics, Inc. 2020 Q1 - Results - Earnings Call Presentation
May 8 Analysts Have Made A Financial Statement On MacroGenics, Inc.'s (NASDAQ:MGNX) First-Quarter Report

Back to the Main MGNX Page...